Elevated alanine transaminase in liver transplant recipients after BNT162b2 vaccination: a cohort study

Elevated alanine transaminase in liver transplant recipients after BNT162b2 vaccination: a cohort study

Abstract Liver transplant (LTx) recipients risk severe COVID-19. Vaccination reduces this risk. However, there may be side effects, including elevated alanine transaminase (ALT) which could lead to increased use of liver biopsy. We aimed to describe prevalence and relative incidence of elevated ALT...

Full description

Saved in:
Bibliographic Details
Main Authors: Jacob Siewertsen Bergmann, Sebastian Rask Hamm, Louise Bering, Christian Ross Pedersen, Ask Bock, Safura-Luise Heidari, Gerda Elisabeth Villadsen, Annette Dam Fialla, Gro Linno Willemoe, Peter Holland-Fischer, Susanne Dam Nielsen
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-025-01233-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41541-025-01233-7

Similar Items